SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,000 | – | 4,000 | +100.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 2,000 | -20.0% | 0.00% | – |
| Q4 2015 | $1,000 | -95.5% | 2,500 | -80.6% | 0.00% | – |
| Q3 2015 | $22,000 | -52.2% | 12,911 | -37.8% | 0.00% | – |
| Q2 2015 | $46,000 | -51.1% | 20,766 | -57.3% | 0.00% | – |
| Q1 2015 | $94,000 | -18.3% | 48,603 | +12.2% | 0.00% | – |
| Q4 2014 | $115,000 | -48.4% | 43,319 | -41.6% | 0.00% | – |
| Q3 2014 | $223,000 | +443.9% | 74,181 | +641.8% | 0.00% | – |
| Q2 2014 | $41,000 | -21.2% | 10,000 | -16.7% | 0.00% | – |
| Q1 2014 | $52,000 | +160.0% | 12,000 | +287.0% | 0.00% | – |
| Q3 2013 | $20,000 | +33.3% | 3,101 | +3.4% | 0.00% | – |
| Q2 2013 | $15,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 30,197,945 | $80,025,000 | 92.06% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 457,458 | $1,212,000 | 0.22% |
| Verity Asset Management, Inc. | 82,383 | $218,000 | 0.21% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,238 | $880,000 | 0.12% |
| Cutler Capital Management, LLC | 62,500 | $165,000 | 0.07% |
| Capital Impact Advisors, LLC | 37,788 | $100,000 | 0.05% |
| SECOR Capital Advisors, LP | 35,087 | $93,000 | 0.04% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 50,814 | $134,000 | 0.04% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |
| BOLTON LP | 37,700 | $100,000 | 0.03% |